Literature DB >> 17182979

History of allergic disease and risk of meningioma.

M J Schoemaker1, A J Swerdlow, S J Hepworth, M van Tongeren, K R Muir, P A McKinney.   

Abstract

Epidemiologic studies have consistently shown inverse associations of allergic disease with risk of glioma, but it is unclear whether this association also applies to meningioma. The authors conducted a pooled analysis of meningioma risk in relation to a history of allergic disease based on data from two population-based, case-control studies with 475 cases and 1,716 controls in the United Kingdom (2001-2004). Meningioma risk was significantly reduced in relation to self-reported, physician-diagnosed allergic disease (odds ratio = 0.76, 95% confidence interval (CI): 0.61, 0.96) but was nonsignificantly reduced for individual conditions: asthma (odds ratio = 0.85, 95% CI: 0.61, 1.18), hay fever (odds ratio = 0.81, 95% CI: 0.62, 1.06), and eczema (odds ratio = 0.72, 95% CI: 0.51, 1.02). Risk reductions were greatest for asthma (odds ratio = 0.43, 95% CI: 0.21, 0.89) and hay fever (odds ratio = 0.50, 95% CI: 0.25, 1.00) with an early age at onset (<10 years) and for eczema (odds ratio = 0.46, 95% CI: 0.21, 1.07) with an onset at ages 10-19 years; they were near unity for onset in adulthood. This study suggests an inverse association between a history of allergies and meningioma risk, but with smaller risk reductions than for glioma. The reasons for this association need clarification, as well as an etiologic explanation. Consideration also needs to be given to confounding or bias.

Entities:  

Mesh:

Year:  2006        PMID: 17182979     DOI: 10.1093/aje/kwk048

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  14 in total

1.  Association of the interleukin-4Rα rs1801275 and rs1805015 polymorphisms with glioma risk.

Authors:  Jun Guo; Lei Shi; Min Li; Jin Xu; Shushan Yan; Chuang Zhang; Guan Sun
Journal:  Tumour Biol       Date:  2013-08-27

2.  Temporal bone meningioma involving the middle ear: A case report.

Authors:  Filippo Ricciardiello; Lucia Fattore; Maria Ester Liguori; Flavia Oliva; Amalia Luce; Teresa Abate; Michele Caraglia; Annalisa Pianese; Aldo Falco Raucci
Journal:  Oncol Lett       Date:  2015-07-20       Impact factor: 2.967

3.  Risk of meningioma and common variation in genes related to innate immunity.

Authors:  Preetha Rajaraman; Alina V Brenner; Gila Neta; Ruth Pfeiffer; Sophia S Wang; Meredith Yeager; Gilles Thomas; Howard A Fine; Martha S Linet; Nathaniel Rothman; Stephen J Chanock; Peter D Inskip
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-04-20       Impact factor: 4.254

4.  Family and personal medical history and risk of meningioma.

Authors:  Elizabeth B Claus; Lisa Calvocoressi; Melissa L Bondy; Joellen M Schildkraut; Joseph L Wiemels; Margaret Wrensch
Journal:  J Neurosurg       Date:  2011-07-22       Impact factor: 5.115

5.  Assessment of autoantibodies to meningioma in a population-based study.

Authors:  Joseph L Wiemels; Paige M Bracci; Margaret Wrensch; Joellen Schildkraut; Melissa Bondy; Jon Pfefferle; Mi Zhou; Jennette Sison; Lisa Calvocoressi; Elizabeth B Claus
Journal:  Am J Epidemiol       Date:  2012-12-06       Impact factor: 4.897

Review 6.  Epidemiology and etiology of meningioma.

Authors:  Joseph Wiemels; Margaret Wrensch; Elizabeth B Claus
Journal:  J Neurooncol       Date:  2010-09-07       Impact factor: 4.130

7.  Childhood and juvenile meningiomas.

Authors:  Xing Gao; Rong Zhang; Ying Mao; Yin Wang
Journal:  Childs Nerv Syst       Date:  2009-07-30       Impact factor: 1.475

8.  History of allergic disease and epilepsy and risk of glioma and meningioma (INTERPHONE study group, Germany).

Authors:  Gabriele Berg-Beckhoff; Joachim Schüz; Maria Blettner; Eva Münster; Klaus Schlaefer; Jürgen Wahrendorf; Brigitte Schlehofer
Journal:  Eur J Epidemiol       Date:  2009-05-31       Impact factor: 8.082

9.  The INTERPHONE study: design, epidemiological methods, and description of the study population.

Authors:  Elisabeth Cardis; Lesley Richardson; Isabelle Deltour; Bruce Armstrong; Maria Feychting; Christoffer Johansen; Monique Kilkenny; Patricia McKinney; Baruch Modan; Siegal Sadetzki; Joachim Schüz; Anthony Swerdlow; Martine Vrijheid; Anssi Auvinen; Gabriele Berg; Maria Blettner; Joseph Bowman; Julianne Brown; Angela Chetrit; Helle Collatz Christensen; Angus Cook; Sarah Hepworth; Graham Giles; Martine Hours; Ivano Iavarone; Avital Jarus-Hakak; Lars Klaeboe; Daniel Krewski; Susanna Lagorio; Stefan Lönn; Simon Mann; Mary McBride; Kenneth Muir; Louise Nadon; Marie-Elise Parent; Neil Pearce; Tiina Salminen; Minouk Schoemaker; Brigitte Schlehofer; Jack Siemiatycki; Masao Taki; Toru Takebayashi; Tore Tynes; Martie van Tongeren; Paolo Vecchia; Joe Wiart; Alistair Woodward; Naohito Yamaguchi
Journal:  Eur J Epidemiol       Date:  2007-07-18       Impact factor: 8.082

10.  Noncutaneous and Cutaneous Cancer Risk in Patients With Atopic Dermatitis: A Systematic Review and Meta-analysis.

Authors:  Lily Wang; Rachel Bierbrier; Aaron M Drucker; An-Wen Chan
Journal:  JAMA Dermatol       Date:  2020-02-01       Impact factor: 10.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.